You are currently viewing a new version of our website. To view the old version click .

Fermentation

Fermentation is an international, peer-reviewed, open access journal on fermentation process and technology, published monthly online by MDPI.

Quartile Ranking JCR - Q2 (Biotechnology and Applied Microbiology)

All Articles (3,929)

Alcoholic liver injury (ALI) is a major global public health issue, with oxidative stress imbalance as its core pathological mechanism. The Kelch-like ECH-associated protein 1–nuclear factor erythroid 2-related factor 2–heme oxygenase-1/glutathione peroxidase 4 signaling pathway (Keap1–Nrf2–HO-1/GPX4) signaling pathway is a key target for regulating hepatic antioxidant defense. This study integrated Ultra Performance Liquid Chromatography-Tandem Mass Spectrometry (UPLC-MS/MS), Global Natural Products Social Molecular Networking (GNPS) molecular networking, network pharmacology, and animal experiments to systematically explore the hepatoprotective effect and mechanism of Cornus officinalis yeast-fermentation (COF). Component characterization identified 25 bioactive components, including flavonoids, triterpenic acids, and other fermentation-derived metabolites. Network pharmacology identified 441 common targets and 36 core targets of COF and ALI, which were enriched in oxidative stress regulation, inflammatory response, and the Keap1–Nrf2 pathway via Gene Ontology (GO)/Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis. Molecular docking showed that icariin and other components had stable interactions with Keap1 and Nrf2 (binding energy < −5 kcal/mol). Animal experiments confirmed that COF reduced the liver index of ALI mice, downregulated serum Alanine Aminotransferase (ALT)/Aspartate Aminotransferase (AST) activities, and ameliorated liver pathological damage. Western blot verified that COF inhibited Keap1 expression, promoted Nrf2 nuclear translocation, and upregulated HO-1/GPX4 expression. In conclusion, COF alleviates hepatic oxidative stress by regulating the Keap1–Nrf2–HO-1/GPX4 pathway, providing a scientific basis for its development as a functional food or candidate drug against ALI and a technical paradigm for fermentation-enhanced medicinal plant research.

5 January 2026

Venn diagram of the COF and ALI targets.

With the rapid growth of the population and the economy, environmental and health issues caused by animal protein consumption have received increasing attention. The world urgently needs alternative proteins as a way out, and microbial proteins have tremendous potential as sustainable protein sources. In this study, Neurospora intermedia FF171 was isolated and identified from Pu-erh fermented tea. FF171 can rapidly produce substantial mycelial biomass using a sugar byproduct as a carbon source. The combination of sugarcane molasses and corn gluten meal as carbon and nitrogen sources, respectively, resulted in a dry biomass of 9.10 ± 0.20 g/L and a protein yield of 6.16 ± 0.11 g/L (67.48% protein content). FF171 exhibits genetic stability, and no mycotoxins were detected in the biomass. Furthermore, the strain’s genome was sequenced and annotated. Bioinformatics analysis, including comparison of specific sequences with reference strains in the GRAS (Generally Recognized as Safe) database, was conducted to assess potential toxicity, allergenicity, and antimicrobial resistance. The results revealed no virulence or pathogenic factors and no antibiotic resistance genes, while the risk of triggering allergic reactions was minimal. Taken together, these findings suggest that Neurospora intermedia FF171 is a safe and promising candidate for mycoprotein production, with strong potential as a future alternative protein source.

4 January 2026

Probiotic Fermentation: A Strategy to Induce the Significant Amplification of Phenolics and Bioactivity in Milk Thistle Seeds

  • Suzana Dimitrijević-Branković,
  • Valentina Nikšić and
  • Milica Milutinović
  • + 4 authors

This study investigates how fermentation of milk thistle seeds (MTSs) by Saccharomyces cerevisiae var. boulardii, alone or with Lacticaseibacillus rhamnosus, affects phenolic compounds content and bioactivity of the resulting extracts. Microwave-assisted extraction parameters were optimized for maximal yield and validated for scale-up. The extracts were analyzed for total phenolic compounds (TPCs), total flavonoid compounds (TFCs), and bioactivities including antioxidant, antimicrobial, and prebiotic effects. Optimal extraction conditions were 70% ethanol, liquid to solid (L/S) ratio 30 mL/g, 180 W power, and 3 min duration, enabling energy-efficient recovery of antioxidants with higher yields than previously reported. Solid-state fermentation with S. boulardii significantly enhanced extraction efficiency, doubling TPC (647.6 ± 24.4 mg GAE/g dm) and TFC (87.04 ± 6.88 mg QE/g dm) contents, and antioxidant capacity (4.27 ± 0.19 mmol Fe2+/g dm) compared to non-fermented MTSs. Fermented extracts fully inhibited Staphylococcus aureus and partially Escherichia coli and Candida albicans. They also promoted the growth of probiotics such as S. boulardii and lactic acid bacteria strains, while non-fermented extracts showed opposite effects. These findings highlight the potential of MTS fermentation as a sustainable strategy to enhance bioactive compound yield and develop functional supplements that support human and animal health.

3 January 2026

Fermented dairy products have been a staple food commodity throughout recorded human history [...]

3 January 2026

News & Conferences

Issues

Open for Submission

Editor's Choice

Reprints of Collections

Fermentation Processes
Reprint

Fermentation Processes

Modeling, Optimization and Control: 2nd Edition
Editors: Ricardo Aguilar-López
Advances in Analysis of Flavors and Fragrances
Reprint

Advances in Analysis of Flavors and Fragrances

Chemistry, Properties and Applications in Food Quality Improvement
Editors: Ana Leahu, Maria Soledad Prats Moya, Cristina Ghinea

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Fermentation - ISSN 2311-5637